Metformin Inhibited GSDME to Suppress M2 Macrophage Pyroptosis and Maintain M2 Phenotype to Mitigate Cisplatin-Induced Intestinal Inflammation

Background: The continuous clinical use of cisplatin is prevented by gastrointestinal toxicity. Methods: Cisplatin was used to treat THP-1-derived macrophages to see its differential effects on different subtypes of macrophages. Wild-type and Gsdme^−/− mice models were used to examine the...

Description complète

Détails bibliographiques

Auteurs principaux:	Ke Jiang, Qi He, Chenhui Wang, Wen Yang, Changdong Zhou, Jian Li, Jiangbo Li, Yuke Cui, Jingqi Shi, Zhenqiao Wei, Yuanyuan Jiao, Ligai Bai, Shengqi Wang, Liang Guo
Format:	Artigo
Langue:	Inglês
Publié:	MDPI AG 2024-11-01
Collection:	Biomedicines
Sujets:	cisplatin gasdermin E M2 macrophages pyroptosis metformin intestinal inflammation
Accès en ligne:	https://www.mdpi.com/2227-9059/12/11/2526
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!